INS and type 2 diabetes mellitus: In this context, there was a clear perception among the Delphi Survey respondents that a significant barrier to incorporating CGM technology into care of people with T2D on insulin is resistance to change among primary care teams, whether based on time constraints of lack of familiarity with technology in this context.